TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE STAGE 5 (CKD 5) BY HEMODIALYSIS AND HEMODIAFILTRATION. CLINICAL GUIDELINES

1. Бикбов БТ, Томилина Н.А. Заместительная терапия больных с хронической почечной недостаточностью в Российской Федерации в 1998–2011 гг. (Отчет по данным Российского регистра заместительной почечной терапии). Нефрология и диализ 2014; 16 (1)

2. Готье СВ, Мойсюк ЯГ, Хомяков СМ. Донорство и трансплантация органов в Российской Федерации. VI сообщение регистра Российского трансплантологического общества. Вестник трансплантологии и искусственных органов 2014; 16 (2)

3. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150: 604–612

4. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int 2013; 3 (1)

5. European Best Practice Guidelines for Haemodialysis (Part 1) Nephrol Dial Transplant (2002) 17 [Suppl 7]

6. European best practice guidelines on haemodialysis (Part 2) Nephrol Dial Transplant (2007) 22 [Suppl 2]:

7. National Kidney Foundation KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006

8. National Kidney Foundation KDOQI Clinical Practice Guidelines for Vascular Access, Update 2006

9. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009;20(3):645-654

10. Grooteman MP, van den Dorpel MA, Bots ML et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 2012;23(6):1087-1096

11. Ok E, Asci G, Toz H et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with highflux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant 2013;28(1):192-202

12. Maduell F, Moreso F, Pons M et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 2013;24(3):487-497

13. Tattersall J et EUDIAL, Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant 2013 ;28(3):542-550

14. Davenport A. Optimization of heparin anticoagulation for hemodialysis. Hemodial Int 2011;15 (suppl 1):43-48

15. Fischer KG. Essentials of anticoagulation in hemodialysis. Hemodial Int 2007;11:178-189

16. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24(5):1574-1579

17. E.Movilli, P.Gaggia, R.Zubani et al. Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. Nephrol Dial Transplant 2007; 22: 3547–3552

18. Dialysate for hemodialysis ANSI/AAMI RD52:2004

19. Смирнов АВ, Нестерова ОБ, Суглобова ЕД и др. Клинико-лабораторная оценка эффективности лечения больных с терминальной стадией почечной недостаточности с использованием хронического гемодиализа и ацидосукцината. Тер Арх 2013; 85 (1): 69-75

20. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993;4(5):1205-1213

21. Daugirdas JT. Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn. Adv Ren Replace Ther 1995;2(4):295-304

22. Gotch FA. Evolution of the single-pool urea kinetic model. Semin Dial 2001;14(4):252-256

23. National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005

24. European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 1999;14 [Suppl 5]

25. Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure Nephrol Dial Transplant 2004;19 [Suppl 2]

26. National Kidney Foundation KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target

27. KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease Kidney Int Supplements 2012; Vol 2, Issue 4, August (2)

28. National Kidney Foundation KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease 2003

29. KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD–MBD). Kidney Int 2009; Vol 76, Suppl 113

30. National Kidney Foundation KDOQI Nutrition Guidelines American Journal of Kidney Diseases,Vol 35, No 6, Suppl 2, 2000: S1-S3

31. National Kidney Foundation KDOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 2005

32. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383

33. Floege J, Kim J, Ireland E et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant 2011; 26:1948–1955

34. Zimmermann J, Herrlinger S, Pruy A et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55(2):648-658

35. Robinson BM, Tong L, Zhang J et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2012;82(5):570-580